Our services

image6

  

· Thought leadership working with Regulatory Authorities and Sponsors to develop the most appropriate pathways for Rx to OTC Switch

· Assessment and analysis of both the the Regulatory and Commercial Opportunity

· Design and preparation of the Drug Facts Label 

· Hands on development of the molecule through the appropriate Switch pathway in consultation with the FDA

· Preparation for the initial Pre-IND meeting

· Design and implementation of the  required studies including label comprehension, self-selection and actual-use

· Preparation for Advisory Committee Review

 

Subscribe

Sign up to hear from us.

Contact Us

Prequient

PO Box 128, Mountain Lakes, New Jersey, 07046, USA

(973) 334-4710

Send Message

Cancel

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.